ClearLLab Antibody Solutions

Beckman Coulter is revolutionizing the leukemia and lymphoma analysis in clinical flow cytometry laboratories with the innovative ClearLLab Solutions:

  • ClearLLab Reagents are the first reagents to receive US Food and Drug Administration (FDA) clearance (via the De Novo Process) for leukemia and lymphoma* flow cytometric immunophenotyping in the clinical lab.
  • ClearLLab Reagents are comprised of five pre-formulated antibody cocktails targeted at B-, T-, and Myeloid cell malignancies, significantly reducing validation time thanks to IVD status 
  • ClearLLab Antibody solutions are compatible with current Clinical Guidelines

*For Non-Hodgkin’s lymphoma only